TL;DR
This paper introduces a new method for accurately determining sample sizes in clinical trials with composite binary endpoints, accounting for unknown correlation and parameter uncertainty, supported by a web tool and simulation validation.
Contribution
It presents a novel strategy for sample size calculation that handles unknown correlation and parameter uncertainty, improving trial design robustness.
Findings
Sample size is highly sensitive to correlation assumptions.
Small deviations in marginal parameters can lead to underpowered trials.
The proposed method effectively accounts for uncertainty in parameters.
Abstract
Composite binary endpoints are increasingly used as primary endpoints in clinical trials. When designing a trial, it is crucial to determine the appropriate sample size for testing the statistical differences between treatment groups for the primary endpoint. As shown in this work, when using a composite binary endpoint to size a trial, one needs to specify the event rates and the effect sizes of the composite components as well as the correlation between them. In practice, the marginal parameters of the components can be obtained from previous studies or pilot trials, however, the correlation is often not previously reported and thus usually unknown. We first show that the sample size for composite binary endpoints is strongly dependent on the correlation and, second, that slight deviations in the prior information on the marginal parameters may result in underpowered trials for…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
